<DOC>
	<DOC>NCT00346866</DOC>
	<brief_summary>The purpose of this study was to evaluate the efficacy of anecortave acetate for depot suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual acuity in patients with wet AMD.</brief_summary>
	<brief_title>Anecortave Acetate Versus Placebo in AMD Patients Following PDT</brief_title>
	<detailed_description />
	<mesh_term>Anecortave</mesh_term>
	<criteria>AMD disease Age</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>